Form 57.75P Antimicrobial Use and Resistance (AUR) - Microbiology La
The National Healthcare Safety Network (NHSN)
P_AUR Laboratory.ppt
Antimicrobial Use and Resistance (AUR) - Microbiology Laboratory Data
OMB: 0920-0666
⚠️ Notice: This form may be outdated. More recent filings and information on OMB 0920-0666 can be found here:
Document [ppt]
Download:
ppt |
pdf*Facility ID# :
| *Month:
| *Year:
| *Location Code:
|
Do not report duplicate isolates (i.e., the same patient with the same species) or surveillance cultures
|
| Susceptible*
| Intermediate*
| Resistant*
| Total Tested*
|
GRAM POSITIVE ORGANISMS
| | | | |
Coagulase-negative staphylococci
| | | | |
vancomycin
| | | | |
Enterococcus spp.
| | | | |
vancomycin
| | | | |
Staphylococcus aureus
| | | | |
oxacillin
| | | | |
vancomycin
| | | | |
GRAM NEGATIVE ORGANISMS
| | | | |
Acinetobacter spp.
| | | | |
amikacin
| | | | |
cefepime
| | | | |
ceftazidime
| | | | |
imipenem
| | | | |
piperacillin/tazobactam
| | | | |
ampicillin/sulbactam
| | | | |
Enterobacter spp.
| | | | |
cefotaxime
| | | | |
ceftazidime
| | | | |
imipenem
| | | | |
meropenem
| | | | |
Escherichia coli
| | | | |
cefotaxime
| | | | |
ceftazidime
| | | | |
ciprofloxacin
| | | | |
imipenem
| | | | |
Klebsiella pneumoniae
| | | | |
cefotaxime
| | | | |
ceftazidime
| | | | |
imipenem
| | | | |
Pseudomonas aeruginosa
| | | | |
cefepime
| | | | |
ceftazidime
| | | | |
ciprofloxacin
| | | | |
levofloxacin
| | | | |
imipenem
| | | | |
meropenem
| | | | |
piperacillin
| | | | |
amikacin
| | | | |
* Enter zero if not tested. an entry is required on every field.
| | | | |

File Type | application/vnd.ms-powerpoint |
File Title | Slide 1 |
Author | Jasie L. Jackson |
Last Modified By | rfp9 |
File Modified | 2007-07-25 |
File Created | 2007-04-19 |